Format

Send to

Choose Destination
See comment in PubMed Commons below
Prostate Cancer Prostatic Dis. 2008;11(2):129-33. Epub 2007 Jun 26.

Dutasteride significantly improves quality of life measures in patients with enlarged prostate.

Author information

  • 1Brigham and Women's Hospital, Boston, MA 02115, USA. moleary1@partners.org

Abstract

The purpose of this study was to determine the effect of dutasteride on quality of life of men with lower urinary tract symptoms associated with enlarged prostate or benign prostatic hyperplasia (BPH) as measured by symptom problem index (SPI), BPH-specific interference with activities (BSIA), BPH-specific psychological well-being (BPWB) and BPH-specific lifestyle adaptations (BSLA). Data were derived from three randomized, double-blind studies conducted in 4325 men treated with placebo or dutasteride (0.5 mg/day). Primary analyses included changes from baseline in mean SPI, BSIA, BPWB and BSLA scores. Men treated with dutasteride showed significant improvements in SPI, BSIA, BPWB and BSLA scores compared with placebo.

PMID:
17592479
DOI:
10.1038/sj.pcan.4500990
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Support Center